Target intelligence / Profile preview

Daboia russelii siamensis snake venom metalloproteinase (SVMP) (SVMP)

Target
SVMP
Molecular classification
Enzyme, Metalloproteinase, Zinc-dependent endopeptidase, Snake venom toxin
01

Overview

Daboia russelii siamensis snake venom metalloproteinases (SVMPs) are a major class of zinc-dependent enzymes found in the venom of the Eastern Russell's Viper (UniProt: P86540). These enzymes are primarily responsible for the severe local and systemic hemorrhage and tissue necrosis characteristic of envenomation (PubMed: 26003026). SVMPs function by proteolytically degrading the basement membrane and extracellular matrix of blood vessels, leading to vascular leakage and internal bleeding (PubMed: 30145355). Additionally, certain SVMPs in this species act as procoagulants by activating Factor X or prothrombin, contributing to life-threatening consumption coagulopathy (PubMed: 28235563). Therapeutically, these proteins are the primary targets of antivenoms, which use polyclonal antibodies to neutralize their toxic effects (WHO: Snake Antivenoms). Research is also focused on small-molecule inhibitors like batimastat, which competitively bind the zinc atom in the enzyme's active site to prevent tissue damage (PubMed: 29111116). These inhibitors are being explored as potential field-stable treatments to be administered immediately after a bite to mitigate permanent physical disability.

Other names
Russell's viper venom metalloproteinaseRVV-MPHemorrhagic toxinZinc-dependent metalloproteinaseDaboia russelii siamensis SVMP
02

Mechanism of action

Neutralization of toxic enzymatic activity through antibody-mediated binding (antivenom) or competitive inhibition of the zinc-dependent catalytic site (PubMed: 29111116).

03

Biological functions

ProteolysisHemorrhage inductionProthrombin activationExtracellular matrix degradationBasement membrane degradation
04

Disease associations

Snakebite envenomationHemorrhageCoagulopathyTissue necrosisAcute kidney injury
05

Safety considerations

Anaphylaxis to equine- or ovine-derived antivenomSerum sicknessOff-target inhibition of human matrix metalloproteinases (MMPs) by small-molecule inhibitors
06

Interacting drugs

Russell's Viper Antivenom

3 more in the full profile.

07

Biomarkers

Prothrombin time (PT)International Normalized Ratio (INR)Fibrinogen levelVenom antigen concentration (ELISA)

Beyond the preview

Go deeper on Daboia russelii siamensis snake venom metalloproteinase (SVMP) (SVMP).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Daboia russelii siamensis snake venom metalloproteinase (SVMP) (SVMP).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call